Click here to get full coverage on Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

Why Chimerix Inc. (CMRX) is Surging in 2025  Yahoo Finance

Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

Click here to get full coverage on Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq

Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market  Nasdaq

Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq

Click here to get full coverage on Chimerix Inc. (CMRX) reports earnings - qz.com

Chimerix Inc. (CMRX) reports earnings  qz.com

Chimerix Inc. (CMRX) reports earnings - qz.com

Click here to get full coverage on Why Chimerix, Inc. (CMRX) Soared Last Week - Yahoo Finance

Why Chimerix, Inc. (CMRX) Soared Last Week  Yahoo Finance

Why Chimerix, Inc. (CMRX) Soared Last Week - Yahoo Finance

Click here to get full coverage on Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M? - Stock Titan

Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M?  Stock Titan

Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M? - Stock Titan

Click here to get full coverage on Exploring Three High Growth Tech Stocks in the United States - simplywall.st

Exploring Three High Growth Tech Stocks in the United States  simplywall.st

Exploring Three High Growth Tech Stocks in the United States - simplywall.st

Click here to get full coverage on Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play - Seeking Alpha

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play  Seeking Alpha

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play - Seeking Alpha

Click here to get full coverage on Chimerix Stock Soars: Time to Buy? - StocksToTrade

Chimerix Stock Soars: Time to Buy?  StocksToTrade

Chimerix Stock Soars: Time to Buy? - StocksToTrade

Click here to get full coverage on Chimerix Stock Soars: Time to Reconsider? - timothysykes.com

Chimerix Stock Soars: Time to Reconsider?  timothysykes.com

Chimerix Stock Soars: Time to Reconsider? - timothysykes.com

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Click here to get full coverage on Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?  Yahoo Finance

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance

Click here to get full coverage on Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo Finance

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025  Yahoo Finance

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo Finance

Click here to get full coverage on Chimerix Inc.: Is a Breakthrough in Drug Development the Key to a Stock Surge? - timothysykes.com

Chimerix Inc.: Is a Breakthrough in Drug Development the Key to a Stock Surge?  timothysykes.com

Chimerix Inc.: Is a Breakthrough in Drug Development the Key to a Stock Surge? - timothysykes.com

Click here to get full coverage on Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX) - Nasdaq

Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)  Nasdaq

Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX) - Nasdaq

Click here to get full coverage on Chimerix Inc (CMRX) Quarterly 10-Q Report - qz.com

Chimerix Inc (CMRX) Quarterly 10-Q Report  qz.com

Chimerix Inc (CMRX) Quarterly 10-Q Report - qz.com

Click here to get full coverage on CMRX - Chimerix Latest Stock News & Market Updates - Stock Titan

CMRX - Chimerix Latest Stock News & Market Updates  Stock Titan

CMRX - Chimerix Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing - Yahoo Finance

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing  Yahoo Finance

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing - Yahoo Finance

Click here to get full coverage on Chimerix to Participate in Upcoming Investor Conferences - Stock Titan

Chimerix to Participate in Upcoming Investor Conferences  Stock Titan

Chimerix to Participate in Upcoming Investor Conferences - Stock Titan

Click here to get full coverage on CMRX Stock Skyrockets in 3 Months: Here's What You Should Know - Yahoo Finance

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know  Yahoo Finance

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio - Yahoo Finance

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio  Yahoo Finance

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio - Yahoo Finance

Click here to get full coverage on Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer - Stock Titan

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer  Stock Titan

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer - Stock Titan

Click here to get full coverage on Chimerix (CMRX) Stock Price, News & Analysis - MarketBeat

Chimerix (CMRX) Stock Price, News & Analysis  MarketBeat

Chimerix (CMRX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Chimerix: A High-Risk 'Lottery Ticket' (NASDAQ:CMRX) - Seeking Alpha

Chimerix: A High-Risk 'Lottery Ticket' (NASDAQ:CMRX)  Seeking Alpha

Chimerix: A High-Risk 'Lottery Ticket' (NASDAQ:CMRX) - Seeking Alpha

Click here to get full coverage on Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023 - Stock Titan

Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023  Stock Titan

Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023 - Stock Titan

Click here to get full coverage on Chimerix: Q3 Earnings Snapshot - qz.com

Chimerix: Q3 Earnings Snapshot - qz.com

Click here to get full coverage on Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement - Stock Titan

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement  Stock Titan

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement - Stock Titan

Click here to get full coverage on Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting - Stock Titan

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting  Stock Titan

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting - Stock Titan

Click here to get full coverage on 7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes - InvestorPlace

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes  InvestorPlace

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes - InvestorPlace

Click here to get full coverage on Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial - Stock Titan

Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial  Stock Titan

Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial - Stock Titan

Click here to get full coverage on Early movers: LMT, GE, GM, AAPL, MSFT, T, CMRX & more - CNBC

Early movers: LMT, GE, GM, AAPL, MSFT, T, CMRX & more  CNBC

CMRX

Price Chart

Key Statistics

Technicals

About CMRX

Latest News

Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq

Chimerix Inc. (CMRX) reports earnings - qz.com

Advanced Charts

Top Gainers

Top Losers